Univest
Univest
  • Markets

Suven Life Sciences (SUVEN) Share Price Rises 5.52% to Rs 298.35

  • October 12, 2026
  • Posted by: Kunal Singla
  • Category: News
No Comments
Suven Life Sciences Share Price
Suven Life Sciences Ltd. (SUVEN) share price rose to Rs 298.35 today, up 5.52% from the previous close. Market cap was Rs 7,989.46 crore.

Suven Life Sciences Share Price is trading higher today, with the stock at Rs 298.35 after a 5.52% move from the previous close of Rs 282.75. Suven Life Sciences Share Price is also being tracked with a market capitalisation of Rs 7,989.46 Cr, which keeps the stock relevant in today’s market update. Univest figures confirm the price action, but they do not point to a specific company trigger.

For readers tracking Suven Life Sciences Share Price Today, the move is notable because the stock touched Rs 298.35 as the day high and was also the last traded price in the latest Univest figures. The opening price was Rs 286.4 and the day low was Rs 286.2, showing a narrow intraday band. Suven Life Sciences Stock News is therefore centred on verified price action rather than a stated trigger. Investors following Suven Life Sciences Share Price can next monitor how the stock behaves around this level, while Univest keeps the focus on factual market context.

Table of Contents

Toggle
  • Suven Life Sciences Share Price Today: Price Action Analysis
  • Suven Life Sciences Ltd. (SUVEN) Fundamental Analysis
  • Sector and Industry Context
  • Peer Comparison
  • Why Investors Are Watching Suven Life Sciences
  • About Suven Life Sciences
  • Frequently Asked Questions
    • Why is Suven Life Sciences Share Price rising today?
    • What is Suven Life Sciences Share Price today?
    • How much did Suven Life Sciences Share Price rise?
    • What is Suven Life Sciences market cap?
    • Is Suven Life Sciences expensive compared with peers?
    • What do Suven Life Sciences ROE and ROCE show?
    • What is Suven Life Sciences EPS and book value?
    • Does Suven Life Sciences pay a dividend?
  • Track Suven Life Sciences Share Price on Univest

Suven Life Sciences Share Price Today: Price Action Analysis

Metric Value
Current Price Rs 298.35
Previous Close Rs 282.75
Today's Move Rs 15.6 (+5.52%)
Open Rs 286.4
High Rs 298.35
Low Rs 286.2
Market Capitalisation Rs 7,989.46 crore
Market Cap Category Mid Cap

Suven Life Sciences Ltd. (SUVEN) rose to Rs 298.35 from the previous close of Rs 282.75, a move of Rs 15.6 or 5.52%. The stock opened at Rs 286.4, reached a high of Rs 298.35, recorded a low of Rs 286.2.

Suven Life Sciences Share Price rose Rs 15.6, or 5.52%, to Rs 298.35 in today’s trade. The stock opened at Rs 286.4, moved between Rs 286.2 and Rs 298.35, and last traded at the day high. Suven Life Sciences Share Price Today is therefore showing a firm intraday gain against the previous close of Rs 282.75.

The move is cleanly reflected in the price action and does not need a stated catalyst to be meaningful. Suven Life Sciences Share Price also places the company at a market cap of Rs 7,989.46 Cr, which gives context to the size of the move. In Univest tracking terms, the stock is a top gainer today on a price basis, and the verified numbers are enough to explain why it stands out in market updates. The next layer is fundamental analysis, where Suven Life Sciences Share Price can be compared with valuation and return ratios.

Suven Life Sciences Ltd. (SUVEN) Fundamental Analysis

Metric Value
Market Capitalisation Rs 7,989.46 crore
P/B Ratio 14.35x
ROE -101.8%
ROCE -78.71%
EPS Rs -12.47
Book Value Per Share Rs 19.71
Dividend Yield 0%

Suven Life Sciences Ltd. (SUVEN) fundamental metrics show P/B 14.35x, ROE -101.8%, ROCE -78.71%. Taken on their own, these numbers offer context rather than a trading signal.

Suven Life Sciences Ltd. has a market capitalisation of Rs 7,989.46 crore and falls in the Mid Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/B at 14.35x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of -101.8% and ROCE of -78.71%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs -12.47, book value per share of Rs 19.71, dividend yield of 0%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 31.5x, median ROE of 11.22%, median ROCE of 13.1%. They set out the fundamental picture and are not a rating on the stock.

Sector and Industry Context

Metric Value
Sector Healthcare
Industry Pharmaceuticals & Drugs
Benchmark Scope same industry
Benchmark Median P/E 31.5x
Benchmark Average P/E 47.12x
Benchmark P/E Range 3.56x to 679.32x
Company P/B Ratio 14.35x
Benchmark Median P/B 2.83x
Company ROE -101.8%
Benchmark Median ROE 11.22%
Company ROCE -78.71%
Benchmark Median ROCE 13.1%
Company Market Capitalisation Rs 7,989.46 crore
Benchmark Median Market Cap Rs 709.64 crore

Suven Life Sciences Ltd. (SUVEN) operates in the Healthcare sector, within the Pharmaceuticals & Drugs industry.

Suven Life Sciences Ltd. (SUVEN) has a ROE of -101.8%, which is below the benchmark median of 11.22%, a difference of -1,007.31%. Suven Life Sciences Ltd. (SUVEN) has a ROCE of -78.71%, which is below the benchmark median of 13.1%, a difference of -700.84%.

Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.

Peer Comparison

Company Symbol Market Cap (Cr) P/E P/B ROE (%) ROCE (%)
Sun Pharmaceutical Industries Ltd. SUNPHARMA 4,21,539.16 34.85 4.87 14.85 19.11
Divi's Laboratories Ltd. DIVISLAB 2,47,576 84.64 14.02 16.19 21.51
Torrent Pharmaceuticals Ltd. TORNTPHARM 1,77,251.42 81.27 19.75 26.76 19.27
Zydus Lifesciences Ltd. ZYDUSLIFE 1,11,231.65 24.65 4.13 19.69 21.39
Laurus Labs Ltd. LAURUSLABS 1,09,796.85 100.42 19.47 18.31 18.2

Its ROE of -101.8% compares with a peer median of 18.31% across the companies shown in the table. ROCE stood at -78.71% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Suven Life Sciences Ltd. (SUVEN) has a market capitalisation of Rs 7,989.46 crore. All 5 peers shown have a larger market capitalisation.

Why Investors Are Watching Suven Life Sciences

  • Suven Life Sciences Share Price rose 5.52% to Rs 298.35, making the stock stand out in today’s market update.
  • The move happened without a company-specific catalyst being established, so the price action itself is the verified event.
  • Suven Life Sciences Share Price carries a P/B of 14.35, which is above the industry median and average.
  • ROE of minus 101.8% and ROCE of minus 78.71% remain central to Suven Life Sciences Stock Analysis.
  • Univest data places Suven Life Sciences Share Price in a sector where peers show very different P/E, P/B and return profiles.

About Suven Life Sciences

Suven Life Sciences Ltd. operates in Healthcare and belongs to the Pharmaceuticals & Drugs industry. The company is followed through Suven Life Sciences Share Price because its market context combines price action with valuation and return metrics that matter to investors. In the latest Univest figures, the company is tracked with a market cap of Rs 7,989.46 Cr, a P/B ratio of 14.35, EPS of minus 12.47 and book value of Rs 19.71.

Its current profile is also shaped by ROE of minus 101.8% and ROCE of minus 78.71%, while dividend yield is 0. Suven Life Sciences Share Price therefore sits in a business context where the accounting base per share is much lower than the trading price, and where the return metrics need to be read with care. For readers scanning Suven Life Sciences Company News, the key point is that the company remains positioned within a sector that includes large, profitable peers with very different valuation structures.

Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Reg. No. INH000013776, a subsidiary of Univest Communication Technologies Private Limited).

Frequently Asked Questions

Why is Suven Life Sciences Share Price rising today?

Ans. Suven Life Sciences Share Price is rising today because it moved 5.52% higher to Rs 298.35. Univest figures confirm the price action, but they do not point to a specific company trigger.

What is Suven Life Sciences Share Price today?

Ans. Suven Life Sciences Share Price Today is Rs 298.35, compared with the previous close of Rs 282.75. The stock also touched Rs 298.35 as the day high in the latest Univest figures.

How much did Suven Life Sciences Share Price rise?

Ans. Suven Life Sciences Share Price rose Rs 15.6, which works out to 5.52% from the previous close. That move is the main market event visible in today’s trading update.

What is Suven Life Sciences market cap?

Ans. Suven Life Sciences Market Cap stands at Rs 7,989.46 Cr. This places the company above the industry median market capitalisation of Rs 709.64 Cr and below the industry average of Rs 13,386.49 Cr.

Is Suven Life Sciences expensive compared with peers?

Ans. Suven Life Sciences Share Price carries a P/B of 14.35, above the industry median of 2.83 and average of 4.19. Compared with peers, it sits near Divi's Laboratories Ltd. and below Torrent Pharmaceuticals Ltd. and Laurus Labs Ltd.

What do Suven Life Sciences ROE and ROCE show?

Ans. Suven Life Sciences reports ROE of minus 101.8% and ROCE of minus 78.71%. In fundamental analysis, those numbers indicate that return metrics remain weak relative to the industry benchmark.

What is Suven Life Sciences EPS and book value?

Ans. Suven Life Sciences EPS is minus 12.47 and book value is Rs 19.71. EPS reflects earnings per share, while book value shows the accounting net worth behind each share.

Does Suven Life Sciences pay a dividend?

Ans. Suven Life Sciences dividend yield is 0%, so there is no dividend yield contribution in the current valuation view. Suven Life Sciences Share Price is therefore being assessed mainly through price action and fundamentals.

Track Suven Life Sciences Share Price on Univest

Use Suven Life Sciences Ltd. (SUVEN) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.

You can track Suven Life Sciences Share Price on Univest for live updates, fundamental ratios, 52-week levels and market insights. Suven Life Sciences Share Price Today, sector context and peer comparisons are all available in one place for quick monitoring. Univest also helps users follow Suven Life Sciences Stock News and Suven Life Sciences Share Price Update without losing the wider valuation picture.



Author: Kunal Singla
Kunal Singla is the Associate Director - Research at Univest, leading quantitative equity research, intraday trading setups, and derivatives strategy. With 4+ years of experience in Indian equity markets, he combines rigorous quantitative methods with classical technical analysis to build high-conviction research frameworks for retail and advisory clients. He holds an MSc from the Indian Institute of Technology (IIT) Delhi — one of India's most selective institutions — and has completed the Certificate in Quantitative Finance (CQF), a globally recognised programme covering derivatives pricing, risk modelling, machine learning for finance, and advanced portfolio theory. This combination places him in a small group of Indian analysts with both deep academic training in quantitative methods and SEBI-recognised research credentials. Kunal holds seven SEBI-recognised NISM certifications spanning research, derivatives, portfolio management, and securities operations: Series-XV (Research Analyst), Series-XXI-A (Portfolio Managers), Series-XVI (Commodity Derivatives), Series-VIII (Equity Derivatives), Series-VII (SORM), Series-V-A (Mutual Fund Distributors), and Series-I (Currency Derivatives). At Univest — India's SEBI-registered research and advisory platform — Kunal leads research inputs for Pro Lite, Pro Super, Pro Gold, and Pro Commodity advisory services, alongside publishing intraday stock picks on Univest Blogs.

Leave a Reply Cancel reply